Both in Pharmaceuticals
Eledon Pharmaceuticals vs Evommune
Over the past year ELDN returned −34.1% and EVMN returned −70.1%; their daily moves had a correlation of 0.22.
ELDN −34.1% EVMN −70.1%Growth of $1, one year, split-adjusted
| Metric | ELDN | EVMN |
|---|---|---|
| Price | $2.70 | $6.04 |
| Market cap | $219.4M | $219.2M |
| Today | +3.05% | +1.68% |
| 1 month | +10.2% | −8.6% |
| 6 months | −28.9% | −74.7% |
| Year to date | +78.8% | −64.7% |
| 1 year | −38.1% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $88.8M | $200.4M |
| Dividend yield | — | — |
| Volatility (60d) | 61.6% | 87.2% |
| Short % of float | 9.7% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).